• Citer

The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial

par Debien, Véronique;Agostinetto, Elisa;Bruzzone, Marco;Ceppi, Marcello;Martins-Branco, Diogo;Molinelli, Chiara;Jacobs, Flavia;Marta, Guilherme Nader;Lambertini, Matteo Md Phd M.;de Azambuja, Evandro
Référence Clinical breast cancer
Publication Publié, 2024-10-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial
Auteur:	Debien, Véronique; Agostinetto, Elisa; Bruzzone, Marco; Ceppi, Marcello; Martins-Branco, Diogo; Molinelli, Chiara; Jacobs, Flavia; Marta, Guilherme Nader; Lambertini, Matteo Md Phd M.; de Azambuja, Evandro
Informations sur la publication:	Clinical breast cancer
Statut de publication:	Publié, 2024-10-01
Sujet CREF:	Cancérologie
Mots-clés:	Complete response
	HER2-positive breast cancer
	Imaging
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1526-8209
	info:doi/10.1016/j.clbc.2024.02.012
	info:pii/S1526820924000508
	info:scp/85188661048
	info:pmid/38514306